SEC staff rec­om­mends en­force­ment ac­tion against Al­lar­i­ty over po­ten­tial fed­er­al se­cu­ri­ties laws vi­o­la­tions

Strug­gling biotech Al­lar­i­ty Ther­a­peu­tics re­ceived no­tice from the Se­cu­ri­ties and Ex­change Com­mis­sion that the agency’s staff has rec­om­mend­ed it take ac­tion against the com­pa­ny over …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER